On Tuesday, Alcoa Inc (NYSE:AA)’s shares declined -4.04% to $9.50.
For the fourteenth year in a row, lightweight metals leader Alcoa (AA) has been named as one of the world’s leading companies for sustainability on the prestigious Dow Jones Sustainability Indices (DJSI)—a globally recognized and reputable benchmark for corporate responsibility and sustainability. Alcoa was again recognized as the Aluminum Industry Leader on the Dow Jones World Index.
Over the last year, Alcoa expanded its multi-material value-add portfolio and introduced innovations across its end markets enabling customers to produce more environmentally friendly products. The Company also reduced its overall emissions by closing and curtailing high-cost, less efficient facilities as it continued to reshape its commodity business.
Highlights of Alcoa’s industry-leading sustainability performance comprise:
- Reduced absolute greenhouse gas emissions by 3 million metric tons, or 6.8 percent.
- Developed forging for the world’s first hybrid-metallic fan blade, assisting make Pratt & Whitney’s PurePower® engines lighter and more fuel efficient.
- Unveiled Alcoa MicromillTM technology; will manufacture most advanced aluminum sheet on the market, supporting the creation of lighter, more fuel efficient, safer vehicles.
- Introduced Ultra ONETM heavy-duty truck wheel; 47 percent lighter than steel wheel of same size, enables trucks to enhance fuel efficiency and payload.
- Named the World’s Most Active Organization by the Global Corporate Challenge for the second successive year.
Alcoa Inc. produces and manages primary aluminum, fabricated aluminum, and alumina worldwide. The company operates through four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions. The Alumina segment is involved in mining bauxite, which is then refined into alumina. The Primary Metals segment produces primary aluminum.
Johnson & Johnson (NYSE:JNJ)’s shares gained 0.14% to $93.26.
Johnson & Johnson (JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, Oct. 13th, to review third-quarter results. Gary Pruden, Worldwide Chairman, Medical Devices; Dominic Caruso, Vice President, Finance and Chief Financial Officer and Louise Mehrotra, Vice President, Investor Relations, will host the call.
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
At the end of Tuesday’s trade, Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF)‘s shares surged 9.86% to $4.01.
Can-Fite BioPharma Ltd. (CANF) a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, recently declared the U.S. Food and Drug Administration (FDA) has granted the Company’s drug candidate CF102 Fast Track designation as a second line treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer. CF102 had already received the FDA’s Orphan Drug designation.
Can-Fite is presently conducting a Phase II study for this indication in the U.S., Europe and Israel. The randomized, double blind, placebo controlled study is predictable to complete enrollment by the end of the first half of 2016 in 78 patients with Child-Pugh Class B cirrhosis who failed the only FDA approved drug on the market, Nexavar® (sorafenib). Patients are treated twice daily with 25 mg of oral CF102, which has been found to be the most efficacious dose in Can-Fite’s earlier Phase I/II study resulting in the longest overall survival time, with excellent safety results.
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. It offers CF101, which has accomplished Phase II/III clinical trials for the treatment of psoriasis; accomplished Phase II clinical trials for the treatment of rheumatoid arthritis; accomplished Phase I clinical study for the treatment of osteoarthritis; and accomplished Phase I study for the treatment of uveitis, in addition to is in Phase II clinical trials for the treatment of glaucoma or related syndromes of ocular hypertension.
General Mills, Inc.(NYSE:GIS), ended its Tuesday’s trading session with 0.58% gain, and closed at $57.12.
Recently General Mills declared the re-launch of its new and improved digital platform, QueRicaVida.com. Harnessing the power of innovation and mobile technology, General Mills is creating a brand new site and mobile experience to meet the needs of the new Latina and her mobile lifestyle.
According to a study by IAB, Latina moms are leading mobile first lives with nearly 40 percent of Latina moms relying on mobile devices as their primary internet source. With social, digital and mobile playing an important role in their everyday lives, General Mills redesigned their new site to be socially intuitive and mobile friendly.
The improved website has more rich, diverse and relevant content and offers valuable recipes, savings and nutritional information in a way that is more convenient for consumers.
Contemporary Design
The site was created with mobile efficiency in mind. The clean, clear, fluid design makes cooking from any smartphone easier and more enjoyable allowing the user to quickly note ingredients and instruction in addition to share, pin and favorite preferred recipes.
Rich Content and Intuitive Navigation
Authentic recipes and relevant articles are now just a couple of simple clicks away. In catering to the consumer and their values of family, diversity and health, QueRicaVida.com now hosts richer and more diverse dishes that celebrate heritage, culture and wellness while also offering fluid and intuitive navigation making exploring and discovering recipes a pleasant experience.
General Mills, Inc. manufactures and markets branded consumer foods in the United States and internationally. It also supplies branded and unbranded food products to the foodservice and commercial baking industries. The company operates in three segments: U.S. Retail, International, and Convenience Stores and Foodservice.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
